Repligen News

Express News | Ecolab Life Sciences and Repligen announced the launch of DuraCycle affinity resin to provide scalable biomanufacturing commercial services.

BreakingsJun 3 20:08

Express News | Ecolab Life Sciences and Repligen Announce the Commercial Launch of Dura Cycle Affinity Resin for Large-Scale Biologic Manufacturing

BreakingsJun 3 20:06

Repligen (RGEN) Down 10.9% Since Last Earnings Report: Can It Rebound?

Yahoo FinanceMay 31 23:31

Despite Lower Earnings Than Five Years Ago, Repligen (NASDAQ:RGEN) Investors Are up 101% Since Then

Yahoo FinanceMay 31 00:37

A Look At The Fair Value Of Repligen Corporation (NASDAQ:RGEN)

Key Insights Using the 2 Stage Free Cash Flow to Equity, Repligen fair value estimate is US$183 Repligen's US$158 share price indicates it is trading at similar levels as its fair value estimate

Simply Wall StMay 27 18:53

Insider Sell: CEO Anthony Hunt Sells 20,072 Shares of Repligen Corp (RGEN)

Yahoo FinanceMay 23 14:12

Repligen(RGEN.US) Officer Sells US$3.38 Million in Common Stock

$Repligen(RGEN.US)$ Officer Hunt Anthony sold 20,072 shares of common stock on May 21, 2024 at an average price of $168.26 for a total value of $3.38 million.Source: Announcement What is statement of

Futu NewsMay 23 05:59

Repligen Insider Sold Shares Worth $3,377,283, According to a Recent SEC Filing

Anthony Hunt, Chief Executive Officer, on May 21, 2024, sold 20,072 shares in Repligen (RGEN) for $3,377,283. Following the Form 4 filing with the SEC, Hunt has control over a total of 163,177 shares

MT NewswiresMay 23 05:17

Repligen Corporation to Present at Upcoming June Investor Conferences

WALTHAM, Mass., May 22, 2024 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it will be presenting at the following

GlobeNewswireMay 22 19:30

Form 144 | Repligen(RGEN.US) Officer Proposes to Sell 3.43 Million in Common Stocks

SEC FILLINGS DISCLOSED/ May 21, $Repligen(RGEN.US)$ Officer Hunt Anthony intends to sell 20,072 shares of its common stock on May 21, with a total market value of approximately $3.43 million. Hunt A

Futu NewsMay 22 04:14

Here's Why It's Unlikely That Repligen Corporation's (NASDAQ:RGEN) CEO Will See A Pay Rise This Year

Key Insights Repligen's Annual General Meeting to take place on 16th of May Salary of US$880.0k is part of CEO Tony Hunt's total remuneration Total compensation is 35% above industry average Rep

Simply Wall StMay 10 18:34

Repligen Corporation to Present at Upcoming May Investor Conferences

WALTHAM, Mass., May 07, 2024 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it will be participating at the

GlobeNewswireMay 7 19:30

Analysts Offer Insights on Healthcare Companies: Biomea Fusion (BMEA), Repligen (RGEN) and Agenus (AGEN)

TipRanksMay 3 19:42

Repligen Is Maintained at Overweight by JP Morgan

Repligen Is Maintained at Overweight by JP Morgan

Dow JonesMay 3 00:55

JP Morgan Maintains Overweight on Repligen, Lowers Price Target to $200

JP Morgan analyst Rachel Vatnsdal maintains Repligen (NASDAQ:RGEN) with a Overweight and lowers the price target from $230 to $200.

BenzingaMay 3 00:45

Repligen Analyst Ratings

Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/02/2024 24.86% JP Morgan $230 → $200 Maintains Overweight 02/22/2024 29.23% Stifel $165 → $207 Maintain

BenzingaMay 3 00:44

UBS Adjusts Price Target on Repligen to $205 From $225, Maintains Buy Rating

Repligen (RGEN) has an average outperform rating and price target range of $170 to $225, according to analysts polled by Capital IQ. Price: 158.57, Change: +0.21, Percent Change: +0.13

MT NewswiresMay 2 23:31

Earnings Call Summary | Repligen(RGEN.US) Q1 2024 Earnings Conference

The following is a summary of the Repligen Corporation (RGEN) Q1 2024 Earnings Call Transcript:Financial Performance:Q1 2024 revenue was $151 million and Repligen is on track to achieve between $300 m

Futu NewsMay 2 02:56 · Conference Call

Repligen Corp (RGEN) Q1 2024 Earnings: A Close Alignment With Analyst Projections

Yahoo FinanceMay 1 21:11

Repligen's Q1 Adjusted Earnings, Revenue Fall

Repligen (RGEN) reported Q1 adjusted earnings Wednesday of $0.28 per diluted share, down from $0.64 a year earlier. Analysts polled by Capital IQ expected $0.30. Revenue for the quarter ended March 31

MT NewswiresMay 1 20:47